MIRM
NASDAQ · Biotechnology
Mirum Pharmaceuticals Inc
$87.88
-1.55 (-1.73%)
Performance
1D
—
1W
—
1M
—
3M
+10.88%
6M
+20.78%
1Y
+86.74%
YTD
+12.57%
Open$88.27
Previous Close$89.43
Day High$88.39
Day Low$84.94
52W High$109.28
52W Low$36.88
Volume—
Avg Volume845.7K
Market Cap5.47B
P/E Ratio—
EPS$-0.48
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$87.61
Above
SMA 200
$68.12
Above
RSI (14)
56.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
17 analysts
Price Target
-24.1% upside
Current
$87.88
$87.88
Target
$66.73
$66.73
$36.90
$66.73 avg
$76.87
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 642.30M | 339.61M | 354.29M |
| Net Income | -28,784,190 | -13,697,335 | 95.30M |
| Profit Margin | -4.5% | -4.3% | 26.9% |
| EBITDA | 5.52M | 2.77M | 155.69M |
| Free Cash Flow | — | — | 58.63M |
| Rev Growth | +89.1% | +89.1% | +17.5% |
| Debt/Equity | 0.98 | 0.98 | 0.71 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $205.20 | +0.13% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $348.43 | -0.38% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.11 | +0.56% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $448.62 | -0.58% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $741.69 | +0.70% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $308.05 | +0.45% | 139.7 | 43.84B |